» Articles » PMID: 37698918

Calorie Restriction Outperforms Bariatric Surgery in a Murine Model of Obesity and Triple-negative Breast Cancer

Abstract

Obesity promotes triple-negative breast cancer (TNBC), and effective interventions are urgently needed to break the obesity-TNBC link. Epidemiologic studies indicate that bariatric surgery reduces TNBC risk, while evidence is limited or conflicted for weight loss via low-fat diet (LFD) or calorie restriction (CR). Using a murine model of obesity-driven TNBC, we compared the antitumor effects of vertical sleeve gastrectomy (VSG) with LFD, chronic CR, and intermittent CR. Each intervention generated weight and fat loss and suppressed tumor growth relative to obese mice (greatest suppression with CR). VSG and CR regimens exerted both similar and unique effects, as assessed using multiomics approaches, in reversing obesity-associated transcript, epigenetics, secretome, and microbiota changes and restoring antitumor immunity. Thus, in a murine model of TNBC, bariatric surgery and CR each reverse obesity-driven tumor growth via shared and distinct antitumor mechanisms, and CR is superior to VSG in reversing obesity's procancer effects.

Citing Articles

Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer.

Devericks E, Brosnan B, Ho A, Glenny E, Malian H, Teegarden D Cancer Metab. 2025; 13(1):11.

PMID: 40001204 PMC: 11863593. DOI: 10.1186/s40170-025-00380-8.


Fasting as an Adjuvant Therapy for Cancer: Mechanism of Action and Clinical Practice.

Xie Y, Ye H, Liu Z, Liang Z, Zhu J, Zhang R Biomolecules. 2024; 14(11).

PMID: 39595613 PMC: 11591922. DOI: 10.3390/biom14111437.


High BMI Is Associated with Changes in Peritumor Breast Adipose Tissue That Increase the Invasive Activity of Triple-Negative Breast Cancer Cells.

Miracle C, McCallister C, Denning K, Russell R, Allen J, Lawrence L Int J Mol Sci. 2024; 25(19).

PMID: 39408921 PMC: 11476838. DOI: 10.3390/ijms251910592.


Obesity Promotes the Ceramide-Mediated NADPH Oxidase in Acute Myeloid Leukemia.

Wang W, Sabol R, Day A, Hathorn T, Clark M, Connell S J Blood Disord Malig. 2024; 2(1).

PMID: 39364061 PMC: 11449433.


Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.

Zhao Z, Wang J, Kong W, Fang Z, Coleman M, Milne G Gynecol Oncol. 2024; 186:126-136.

PMID: 38669767 PMC: 11216885. DOI: 10.1016/j.ygyno.2024.04.012.


References
1.
Sipe L, Chaib M, Korba E, Jo H, Lovely M, Counts B . Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery. Elife. 2022; 11. PMC: 9342954. DOI: 10.7554/eLife.79143. View

2.
Tsui S, Yang J, Zhang X, Docimo Jr S, Spaniolas K, Talamini M . Development of cancer after bariatric surgery. Surg Obes Relat Dis. 2020; 16(10):1586-1595. DOI: 10.1016/j.soard.2020.06.026. View

3.
Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

4.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

5.
Dyck L, Prendeville H, Raverdeau M, Wilk M, Loftus R, Douglas A . Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function. J Exp Med. 2022; 219(3). PMC: 8932531. DOI: 10.1084/jem.20210042. View